DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Vancomycin hydrochlorideis the generic ingredient in seven branded drugs marketed by Ani Pharms Inc, Akorn, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Strides Pharma, Watson Labs, Rxmtm Theraps Llc, Lederle, Baxter Hlthcare, West-ward Pharms Int, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Gland Pharma Ltd, Hainan Poly Pharm, Hikma, Hikma Pharms, Hospira, Hospira Inc, Mylan Labs Ltd, Pharm Assoc, Sagent Pharms, Sandoz, Sandoz Inc, Teva Pharms Usa, Xellia Pharms Aps, Pharmacia And Upjohn, and Samson Medcl, and is included in fifty-one NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Vancomycin hydrochloride has thirty patent family members in twenty-two countries.
There are twenty-two drug master file entries for vancomycin hydrochloride. Twenty-four suppliers are listed for this compound.
Summary for vancomycin hydrochloride
Recent Clinical Trials for vancomycin hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|University of Texas Southwestern Medical Center||Phase 4|
|Saskatchewan Health Authority - Regina Area||N/A|
|Bezmialem Vakif University||Phase 3|
Pharmacology for vancomycin hydrochloride
|Drug Class||Glycopeptide Antibacterial |
Medical Subject Heading (MeSH) Categories for vancomycin hydrochloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Hikma||VANCOMYCIN HYDROCHLORIDE||vancomycin hydrochloride||INJECTABLE;INJECTION||204360-002||Oct 15, 2018||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Aurobindo Pharma Ltd||VANCOMYCIN HYDROCHLORIDE||vancomycin hydrochloride||INJECTABLE;INJECTION||205780-002||Mar 31, 2016||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Rxmtm Theraps Llc||FIRVANQ KIT||vancomycin hydrochloride||FOR SOLUTION;ORAL||208910-002||Jan 26, 2018||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Teva Pharms Usa||VANCOMYCIN HYDROCHLORIDE||vancomycin hydrochloride||INJECTABLE;INJECTION||201251-002||Dec 23, 2015||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.